Studies on melanoma have found that tumor cells secrete inhibitory cytokines, which reduces the infiltration of T cells into the tumor microenvironment, making tumor cells resistant to immune checkpoint inhibitors after activation of AKT induced by mTORC2 [119]. Here, AKT1 is linked to neoplasm.